SCHEMBL3203775

SCHEMBL3203775

CC1=Cc2ccccc2C1c1ccc2ccccc2c1CNc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 3/20 0.43
CYP1A2 P05177 2/20 0.43
ALOX12 P18054 2/20 0.43
HIF1A Q16665 2/20 0.43
PHLPP2 Q6ZVD8 1/20 0.43
KMT2A Q03164 7/20 0.38
MEN1 O00255 6/20 0.38
HTT P42858 2/20 0.36
POLB P06746 1/20 0.34
HPGD P15428 3/20 0.34
ALOX15 P16050 2/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
CDC25B P30305 1/20 0.34
ATM Q13315 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3209964 0.84 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1A2ALOX12HIF1A
SCHEMBL3210033 0.84 KMT2A (0.35) ALDH1A1HSD17B10CYP1A2ALOX12HIF1A
SCHEMBL3202021 0.83 KMT2A (0.40) ALDH1A1HSD17B10CYP1A2KMT2AMEN1
SCHEMBL3206516 0.80 KMT2A (0.40) ALDH1A1HSD17B10CYP1A2KMT2AMEN1
SCHEMBL3213017 0.79 ALDH1A1 (0.42) ALDH1A1HSD17B10CYP1A2ALOX12HIF1A
SCHEMBL3863426 0.79 KMT2A (0.34) KMT2AMEN1KDM4EMAPTTDP1
SCHEMBL3201652 0.78 MAPT (0.42) ALDH1A1HIF1AKMT2AMEN1HTT
SCHEMBL5477612 0.77 KDM1A (0.44) ALDH1A1HSD17B10KMT2AMEN1HPGD
SCHEMBL3201527 0.76 ALDH1A1 (0.40) ALDH1A1HSD17B10CYP1A2ALOX12HIF1A
Hydrochloric Acid SCHEMBL3258604 0.75 KMT2A (0.33) ALDH1A1CYP1A2KMT2AMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732643-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-08 US disclosed
US-7671226-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-02 US disclosed
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME HANAOKA HIDENORI 2010-02-25 US disclosed
EP-1426379-B1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME SUMITOMO CHEMICAL CO (JP) 2009-11-11 EP disclosed
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same HANAOKA HIDENORI 2009-02-26 US disclosed
US-7439379-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20040242410-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-02 US disclosed
EP-1426379-A1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same C1R, C1S, AP1M1 ALDH1A1 1229/4885HSD17B10 274/4885CYP1A2 315/4885
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME C1R, C1S, AP1M1 ALDH1A1 1229/4885HSD17B10 274/4885CYP1A2 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.